195R Sennosides tablets USP 25 mg sugar coated off-white
- Manufacturer
- TIME CAP LABORATORIES, INC | TIME CAP LABORATORIES, INC.
- Effective date
- 2025-02-08
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-06-01 00:54:49
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients (in each tablet)
Sennosides USP, 25 mg
OTC - PURPOSE SECTION
Purpose
Stimulant Laxative
INDICATIONS & USAGE SECTION
Uses
- Relieves occasional constipation (irregularity)
- generally produces bowel movement in 6 to 12 hours
WARNINGS SECTION
Warnings
OTC - DO NOT USE SECTION
Do not use laxative products when abdominal pain, nausea, or vomiting are present unless directed by a doctor
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have
- noticed a sudden change in bowel habits that persists over a period of 2 weeks
OTC - ASK DOCTOR/PHARMACIST SECTION
Ask a doctor or pharmacist before use if you
are taking any other drug. Laxatives may affect how other drugs work. Take this product 2 or more hours before or after other drugs.
OTC - WHEN USING SECTION
When using this product
- do not use for a period longer than 1 week
OTC - STOP USE SECTION
Stop use and ask a doctor if
- rectal bleeding or failure to have a bowel movement occur after use of a laxative. These may be signs of a serious condition.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- swallow tablet (s) with a glass of water.
- swallow tablet (s) whole, do not crush, break or chew.
adults and children 12 years of age and older
2 tablets once or twice daily
children 6 to under 12 years of age
1 tablet once or twice daily
children under 6 years of age
ask a doctor
OTHER SAFETY INFORMATION
Other information
- each tablet contains: calcium 40 mg, sodium 2 mg (VERY LOW SODIUM)
- store between 20°-25°C (68°-77°F)
INACTIVE INGREDIENT SECTION
Inactive ingredients acacia, calcium sulfate anhydrous, carnauba wax, colloidal silicon dioxide, corn starch, croscarmellose sodium, dibasic calcium phosphate dihydrate, FD&C blue #1 aluminum lake, iron oxide, iron oxide black, iron oxide yellow, kaolin, magnesium stearate, maltodextrin, microcrystalline cellulose, polyethylene glycol, povidone, shellac, stearic acid, sugar, talc, titanium dioxide.
OTC - QUESTIONS SECTION
Questions or comments? Call 1-877-290-4008
195R Lax-Time (Sennosides) 25 mg
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bee4fa8d-8d82-423a-a0b5-40a89dd13a99 | Product name | 1 | 20250618 |
| e0d2eb29-08bd-4bba-90d1-c91c68a38767 | Product name | 4 | 20250516 |
| 30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2 | Product name | 5 | 20250304 |
| 334fe8d2-68fb-4331-a576-420e302ec069 | Product name | 7 | 20240320 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| e92765c1-be81-432a-b909-1b10777ec378 | Product name | 1 | 20190208 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 0441a8f5-3835-497c-aedd-bc78cba56b2a | Product name | 1 | 20150317 |
| 87711080-88eb-65c5-b2dd-bf99e700a372 | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49483-083-00 | 2025-02-10 | C162847 | 48780-1 | 2cef2736-67b9-d83d-e063-dadaa90ab31f | 195R Sennosides tablets USP 25 mg sugar coated off-white |
| 49483-083-09 | 2025-02-10 | C162847 | 48780-1 | 2cef2736-67b9-d83d-e063-dadaa90ab31f | 195R Sennosides tablets USP 25 mg sugar coated off-white |
| 49483-083-00 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-67b9-d83d-e063-dadaa90ab31f | 195R Sennosides tablets USP 25 mg sugar coated off-white |
| 49483-083-09 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-67b9-d83d-e063-dadaa90ab31f | 195R Sennosides tablets USP 25 mg sugar coated off-white |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49483-083-00 | LAX-TIME | 50000 in 1 CARTON | TABLET, SUGAR COATED | 50000 | 4 | |
| 49483-083-09 | LAX-TIME | 95 in 1 BOTTLE | TABLET, SUGAR COATED | 95 | 4 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- LAX-TIME
- SENNOSIDES
- IRON OXIDES
- POVIDONE
- SHELLAC
- TITANIUM DIOXIDE
- FERRIC OXIDE YELLOW
- CALCIUM SULFATE ANHYDROUS
- CALCIUM CATION
- CARNAUBA WAX
- STARCH, CORN
- CROSCARMELLOSE SODIUM
- CROSCARMELLOSE
- STEARIC ACID
- FERROSOFERRIC OXIDE
- DIBASIC CALCIUM PHOSPHATE DIHYDRATE
- FD&C BLUE NO. 1 ALUMINUM LAKE
- sennosides a and b
- KAOLIN
- MAGNESIUM STEARATE
- MALTODEXTRIN
- MICROCRYSTALLINE CELLULOSE
- POLYETHYLENE GLYCOL 400
- RAW SUGAR
- TALC
- ACACIA
- SILICON DIOXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 49483-083 | 49483-083-00, 49483-083-09 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LAX-TIME | SENNOSIDES | TIME CAP LABORATORIES, INC | 74a627fc-00e5-eb78-e053-2991aa0abacc | 2025-02-08 | Warnings | 49483-083-09 49483-083-00 49483-083 49483008309 49483008300 2d9bfe42-43c6-fc97-e063-6294a90a31e2 74a627fc-00e5-eb78-e053-2991aa0abacc |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
